(firstQuint)Ursodiol for Treating Parenteral Nutrition Associated Cholestasis in Neonates.

 This is the first randomised controlled study that address the question of the role of ursodiol as treatment of cases of PNAC.

 It includes all neonates with stratification of less than and equal to 32 weeks or more than 32 weeks of gestation.

.

 Ursodiol for Treating Parenteral Nutrition Associated Cholestasis in Neonates@highlight

The purpose of this study is to determine whether ursodiol is effective in the treatment of parenteral nutrition associated cholestasis in neonates.

